COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making
- PMID: 35868676
- PMCID: PMC8934735
- DOI: 10.1016/j.cger.2022.03.006
COVID-19 Vaccines in Older Adults: Challenges in Vaccine Development and Policy Making
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has had strong adverse impacts on vulnerable populations, such as frail older adults. The success of COVID-19 vaccine development, together with extensive global public health efforts, has brought hope to the control of the COVID-19 pandemic. Nevertheless, challenges in COVID-19 vaccine development and vaccination strategies among older people remain. This article reviews vaccinations in older adults, compares COVID-19 vaccine platforms, the efficacy and safety of COVID-19 vaccines in frail older people in long-term care settings, and the challenges of COVID-19 vaccine development and policy making for vaccination strategies in older adults.
Keywords: COVID-19; Disability; Frailty; Immunosenescence; Vaccine.
Copyright © 2022 Elsevier Inc. All rights reserved.
References
-
- WHO coronavirus disease (COVID-19) dashboard. World Health Organization. https://covid19.who.int/ Available at. Accessed January 28, 2022.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical